Trillin inhibits autophagy and promotes apoptosis in hepatocellular carcinoma cells through activation of the mTOR/STAT3 signaling pathway, suggesting its potential as a therapeutic agent for HCC. This evidence concerns the gene MTOR and hepatocellular carcinoma.